How to resolve contradictions in RLM3’s role across necrotrophic vs. biotrophic pathogens?
Hypothesis testing:
RLM3 may regulate distinct defense pathways. For example, it influences callose deposition (anti-necrotrophic) but not JA/ET signaling .
Test cross-talk with salicylic acid (SA) pathways using SA biosynthesis mutants.
Leverage transcriptomics to identify RLM3-dependent genes (e.g., WRKY60 repression) .
What structural features of RLM3 enable broad-spectrum recognition of fungal effectors?
Findings:
Experimental design:
How to address variability in RLM3 expression across plant tissues?
What bioinformatics tools are optimal for analyzing RLM3-linked immune networks?
Why does RLM3 knockout increase susceptibility to some pathogens but not others?